Authors:
TUBIANAHULIN M
HACENE K
CVITKOVICBERTHREAULT F
Citation: M. Tubianahulin et al., ANALYSIS OF VARIABLES ASSOCIATED WITH RECURRENCE METASTASIS IN BREAST-CANCER TUMOR OF LESS-THAN-OR-EQUAL-TO-1 CM/, European journal of cancer, 34, 1998, pp. 448-448
Authors:
TUBIANAHULIN M
HACENE K
BERTHEAULTCVITKOVIC F
Citation: M. Tubianahulin et al., PROGNOSTIC FACTORS IN SMALL BREAST-TUMORS AT THE RENE-HUGUENIN CENTER, La Semaine des hopitaux de Paris, 74(31-32), 1998, pp. 1178-1179
Authors:
BOUCHET C
SPYRATOS F
HACENE K
DURCOS L
BECETTE V
OGLOBINE J
Citation: C. Bouchet et al., PROGNOSTIC VALUE OF UROKINASE PLASMINOGEN-ACTIVATOR IN PRIMARY BREAST-CARCINOMA - COMPARISON OF 2 IMMUNOASSAY METHODS, British Journal of Cancer, 77(9), 1998, pp. 1495-1501
Authors:
DELAGE V
DEYTIEUX S
LEDOUSSAL V
DEGORCE F
BELLANGER L
HACENE K
SEGUIN P
DESCOTES F
SAEZ S
SPYRATOS F
Citation: V. Delage et al., COMPARISON OF A NEW MICROPLATE ESTROGEN-RECEPTOR (ER) ENZYME-IMMUNOASSAY WITH OTHER ER DETECTION METHODS, British Journal of Cancer, 76(4), 1997, pp. 519-525
Authors:
LEDOUSSAL V
COINDRE JM
LEROUX A
HACENE K
TERRIER P
BUI NB
BONICHON F
COLLIN F
MANDARD AM
CONTESSO G
HENRYAMAR M
MACELESECH J
VILAIN MO
JACQUEMIER J
DUPLAY H
SASTRE X
Citation: V. Ledoussal et al., PROGNOSTIC FACTORS FOR PATIENTS WITH LOCALIZED PRIMARY MALIGNANT FIBROUS HISTIOCYTOMA - A MULTICENTER STUDY OF 216 PATIENTS WITH MULTIVARIATE-ANALYSIS, Cancer, 77(9), 1996, pp. 1823-1830
Authors:
COPIGNY F
CHAMPEME MH
BIECHE I
HACENE K
LIDEREAU R
Citation: F. Copigny et al., INT-2 FGF3 AMPLIFICATION IS BETTER INDEPENDENT PREDICTOR OF RELAPSE THAN C-MYC AND C-ERBB-2/NEU AMPLIFICATIONS IN PRIMARY HUMAN BREAST-CANCER/, European journal of cancer, 31A, 1995, pp. 451-451
Authors:
LEDOUSSAL V
TUBIANAHULIN M
HACENE K
SPYRATOS F
LASRY S
GARBAY JR
ROUESSE J
Citation: V. Ledoussal et al., HAVE HISTOLOGICAL GRADE NUCLEAR-COMPONENTS (MSBR) OF SCARFF BLOOM RICHARDSON (SBR) A PROGNOSTIC VALUE FOR LOBULAR INVASIVE BREAST-CARCINOMA, European journal of cancer, 31A, 1995, pp. 666-666
Authors:
TUBIANAHULIN M
HACENE K
MARTIN PM
SPYRATOS F
Citation: M. Tubianahulin et al., PROGNOSTIC FACTOR CLUSTERING IN BREAST-CANCER - BIOLOGY OR CHRONOLOGY, European journal of cancer, 31A(2), 1995, pp. 282-283
Authors:
SCHOLL SM
PALLUD C
BEUVON F
HACENE K
STANLEY ER
ROHRSCHNEIDER L
TANG R
POUILLART P
LIDEREAU R
Citation: Sm. Scholl et al., ANTI-COLONY-STIMULATING FACTOR-I ANTIBODY STAINING IN PRIMARY BREAST ADENOCARCINOMAS CORRELATES WITH MARKED INFLAMMATORY CELL INFILTRATES AND PROGNOSIS, Journal of the National Cancer Institute, 86(2), 1994, pp. 120-126
Citation: Mh. Champeme et al., ONCOGENE AMPLIFICATION PER SE - AN INDEPENDENT PROGNOSTIC FACTOR IN HUMAN BREAST-CANCER, Molecular carcinogenesis, 11(4), 1994, pp. 189-191
Citation: Mh. Champeme et al., INT-2 FGF3 AMPLIFICATION IS A BETTER INDEPENDENT PREDICTOR OF RELAPSETHAN C-MYC AND C-ERBB-2/NEU AMPLIFICATIONS IN PRIMARY HUMAN BREAST-CANCER/, Modern pathology, 7(9), 1994, pp. 900-905
Authors:
SCHOLL S
BEUVON F
PALLUD C
HACENE K
GULLICK W
POUILLART P
LIDEREAU R
Citation: S. Scholl et al., RELEVANCE OF MULTIPLE BIOLOGICAL PARAMETERS IN BREAST-CANCER PROGNOSIS, Journal of cellular biochemistry, 1994, pp. 253-253
Authors:
SPYRATOS F
MARTIN PM
HACENE K
ANDRIEU C
ROMAIN S
FLOIRAS JL
MAGDELENAT H
Citation: F. Spyratos et al., PROGNOSTIC VALUE OF A SOLUBILIZED FRACTION OF EGF RECEPTORS IN PRIMARY BREAST-CANCER USING AN IMMUNOENZYMATIC ASSAY - A RETROSPECTIVE STUDY, Breast cancer research and treatment, 29(1), 1994, pp. 85-95
Authors:
BOUCHET C
SPYRATOS F
MARTIN PM
HACENE K
GENTILE A
OGLOBINE J
Citation: C. Bouchet et al., PRONOSTIC VALUE OF UROKINASE-TYPE PLASMIN OGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS, Bulletin du cancer, 81(9), 1994, pp. 770-779
Authors:
SPYRATOS F
ANDRIEU C
HACENE K
CHAMBON P
RIO MC
Citation: F. Spyratos et al., PS2 AND RESPONSE TO ADJUVANT HORMONE-THERAPY IN PRIMARY BREAST-CANCER, British Journal of Cancer, 69(2), 1994, pp. 394-397
Authors:
BOUCHET C
SPYRATOS F
MARTIN PM
HACENE K
GENTILE A
OGLOBINE J
Citation: C. Bouchet et al., PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS, British Journal of Cancer, 69(2), 1994, pp. 398-405
Authors:
SPYRATOS F
LEDOUSSAL V
TUBIANAHULIN M
HACENE K
ROUESSE J
Citation: F. Spyratos et al., PROBLEMS IN THE EVALUATION OF TISSULAR PR OGNOSTIC PARAMETERS IN BREAST-CANCER - ABOUT THE CENTER-RENE-HUGUENIN EXPERIENCE, Bulletin de l'Academie nationale de medecine, 178(3), 1994, pp. 495-506
Authors:
PALLUD C
LEDOUSSAL V
PICHON MF
PRUDHOMME JF
HACENE K
MILGROM E
Citation: C. Pallud et al., IMMUNOHISTOCHEMISTRY OF PS2 IN NORMAL HUMAN BREAST AND IN VARIOUS HISTOLOGICAL FORMS OF BREAST-TUMORS, Histopathology, 23(3), 1993, pp. 249-256
Authors:
TUBIANAHULIN M
LEDOUSSAL V
HACENE K
ROUESSE J
BRUNET M
Citation: M. Tubianahulin et al., SEQUENTIAL IDENTIFICATION OF FACTORS PREDICTING DISTANT RELAPSE IN BREAST-CANCER PATIENTS TREATED BY CONSERVATIVE SURGERY, Cancer, 72(4), 1993, pp. 1261-1271
Authors:
BRIFFORD M
SPYRATOS F
HACENE K
TUBIANAHULIN M
PALLUD C
GILLES F
ROUESSE J
Citation: M. Brifford et al., EVALUATION OF BREAST-CARCINOMA CHEMOSENSITIVITY BY FLOW CYTOMETRIC DNA ANALYSIS AND COMPUTER-ASSISTED IMAGE-ANALYSIS, Cytometry, 13(3), 1992, pp. 250-258
Authors:
PREDINE J
SPYRATOS F
PRUDHOMME JF
ANDRIEU C
HACENE K
BRUNET M
PALLUD C
MILGROM E
Citation: J. Predine et al., ENZYME-LINKED-IMMUNOSORBENT-ASSAY OF PS2 IN BREAST CANCERS, BENIGN-TUMORS, AND NORMAL BREAST TISSUES - CORRELATION WITH PROGNOSIS AND ADJUVANT HORMONE-THERAPY, Cancer, 69(8), 1992, pp. 2116-2123